Subventricular zone under the neuroinflammatory stress and Parkinson's disease - PubMed (original) (raw)
Review
Subventricular zone under the neuroinflammatory stress and Parkinson's disease
Keiji Mori et al. Cell Mol Neurobiol. 2012 Jul.
Abstract
This review summarizes the effects of neuroinflammatory stress on the subventricular zone (SVZ), where new neurons are constitutively produced in the adult brain, especially focusing on the relation with Parkinson's disease (PD), because the SVZ is under the control of dopaminergic afferents from the substantia nigra (SN). In Lewy bodies-positive-PD, microglia is known to phagocytoze aggregated α-synuclein, resulting in the release of inflammatory cytokines. The neurogenesis in the SVZ should be affected in PD brain by the neuroinflammatory process. The administration of lipopolysaccaharide is available as an alternative model for microglia-induced loss of dopaminergic neurons and also the impairment of stem cell maintenance. Therefore, the research on the neuroinflammatory process in the SVZ gives us a hint to prevent the outbreak of PD or at least slow the disease process.
Similar articles
- The proliferative capacity of the subventricular zone is maintained in the parkinsonian brain.
van den Berge SA, van Strien ME, Korecka JA, Dijkstra AA, Sluijs JA, Kooijman L, Eggers R, De Filippis L, Vescovi AL, Verhaagen J, van de Berg WD, Hol EM. van den Berge SA, et al. Brain. 2011 Nov;134(Pt 11):3249-63. doi: 10.1093/brain/awr256. Brain. 2011. PMID: 22075520 - 6-hydroxydopamine-induced Parkinson's disease-like degeneration generates acute microgliosis and astrogliosis in the nigrostriatal system but no bioluminescence imaging-detectable alteration in adult neurogenesis.
Fricke IB, Viel T, Worlitzer MM, Collmann FM, Vrachimis A, Faust A, Wachsmuth L, Faber C, Dollé F, Kuhlmann MT, Schäfers K, Hermann S, Schwamborn JC, Jacobs AH. Fricke IB, et al. Eur J Neurosci. 2016 May;43(10):1352-65. doi: 10.1111/ejn.13232. Epub 2016 Apr 5. Eur J Neurosci. 2016. PMID: 26950181 - Harnessing neurogenesis for the possible treatment of Parkinson's disease.
Lamm O, Ganz J, Melamed E, Offen D. Lamm O, et al. J Comp Neurol. 2014 Aug 15;522(12):2817-30. doi: 10.1002/cne.23607. Epub 2014 May 9. J Comp Neurol. 2014. PMID: 24723264 Review. - Activated microglia facilitate the transmission of α-synuclein in Parkinson's disease.
Zheng T, Zhang Z. Zheng T, et al. Neurochem Int. 2021 Sep;148:105094. doi: 10.1016/j.neuint.2021.105094. Epub 2021 Jun 8. Neurochem Int. 2021. PMID: 34097990 Review.
Cited by
- Novel Approaches Used to Examine and Control Neurogenesis in Parkinson's Disease.
Salmina AB, Kapkaeva MR, Vetchinova AS, Illarioshkin SN. Salmina AB, et al. Int J Mol Sci. 2021 Sep 4;22(17):9608. doi: 10.3390/ijms22179608. Int J Mol Sci. 2021. PMID: 34502516 Free PMC article. Review. - The A30P α-synuclein mutation decreases subventricular zone proliferation.
Zhang XM, Anwar S, Kim Y, Brown J, Comte I, Cai H, Cai NN, Wade-Martins R, Szele FG. Zhang XM, et al. Hum Mol Genet. 2019 Jul 15;28(14):2283-2294. doi: 10.1093/hmg/ddz057. Hum Mol Genet. 2019. PMID: 31267130 Free PMC article. - Sex Steroids, Adult Neurogenesis, and Inflammation in CNS Homeostasis, Degeneration, and Repair.
Larson TA. Larson TA. Front Endocrinol (Lausanne). 2018 Apr 30;9:205. doi: 10.3389/fendo.2018.00205. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 29760681 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical